From: Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene
gender | Genotype | OR | 95% CI | p-value |
---|---|---|---|---|
men* | TG vs. GG | 1.1 | 0.7 – 2.0 | 0.630 |
men* | TT vs. GG | 1.2 | 0.7 – 2.2 | 0.504 |
women* | TG vs. GG | 0.9 | 0.5 – 1.6 | 0.723 |
women* | TT vs. GG | 0.8 | 0.5 – 1.3 | 0.565 |
histology | ||||
NSCLC-Adenocarcinoma** | TG vs. GG | 1.0 | 0.6 – 1.7 | 0.991 |
NSCLC-Adenocarcinoma** | TT vs. GG | 1.0 | 0.6 – 1.8 | 0.890 |
other NSCLC** | TG vs. GG | 1.0 | 0.6 – 1.8 | 0.873 |
other NSCLC** | TT vs. GG | 0.9 | 0.5 – 1.6 | 0.751 |
SCLC** | TG vs. GG | 1.0 | 0.5 – 1.9 | 0.980 |
SCLC** | TT vs. GG | 1.2 | 0.6 – 2.1 | 0.637 |
smoking exposure (packyears) | ||||
lightly exposed (11–20 PY)*** | TT vs. GG | 1.0 | 0.6 – 1.8 | 0.928 |
lightly exposed (11–20 PY)*** | TG vs. GG | 1.0 | 0.5 – 1.7 | 0.857 |
moderately exposed (21–30 PY)*** | TT vs. GG | 1.0 | 0.6 – 1.7 | 0.960 |
moderately exposed (21–30 PY)*** | TG vs. GG | 0.9 | 0.6 – 1.6 | 0.822 |
highly exposed (31++ PY)*** | TT vs. GG | 0.9 | 0.5 – 1.4 | 0.595 |
highly exposed (31++ PY)*** | TG vs. GG | 0.8 | 0.5 – 1.3 | 0.369 |